Alaunos Therapeutics Inc (FRA:WEK)
€ 1.41 0 (0%) Market Cap: 326.90 Mil Enterprise Value: 325.31 Mil PE Ratio: 0 PB Ratio: 1.65 GF Score: 54/100

ZIOPHARM Oncology Inc Annual Shareholders Meeting Transcript

May 19, 2021 / 01:00PM GMT
Release Date Price: €2.5 (-1.57%)
Heidi M. Hagen
ZIOPHARM Oncology, Inc. - Interim CEO, Principal Executive Officer & Director

Good morning. I am Heidi Hagen, Interim CEO and Director of Ziopharm Oncology, Inc. And it is my pleasure to welcome you to the company's 2021 Annual Meeting of Stockholders, which due to the public health concerns regarding the ongoing coronavirus pandemic, COVID-19, is being held virtually and exclusively online via live-only webcast.

This meeting was called to be held at 9:00 a.m. today, and it is 9:00 a.m. now. I will officially call this meeting to order.

Joining today's webcast are members of the management team, including Adam Levy, EVP Investor Relations and Corporate Communications; and Robert Hadfield, Chief Legal Officer. In addition, the other members of the Board of Directors attending this webcast today are: Christopher Bowden, James Huang, Robert Postma, Mary Thistle, Jaime Vieser and Holger Weis.

Finally, Kristin Keating of RSM US LLP, our independent registered public accounting firm; and Courtney Thorne of Cooley LLP, our outside counsel, are also attending the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot